Agilus Diagnostics Limited Sustainability Profile
Agilus Diagnostics Limited, a prominent player in the diagnostics industry, is headquartered in India and operates extensively across various regions. Founded in 2015, the company has rapidly established itself as a leader in providing innovative diagnostic solutions, particularly in the fields of molecular diagnostics and laboratory services. Agilus Diagnostics offers a diverse range of core products and services, including advanced testing methodologies that ensure accuracy and reliability. Their commitment to quality and cutting-edge technology sets them apart in a competitive market. With a focus on enhancing patient care, Agilus has achieved significant milestones, including strategic partnerships and expansions that bolster its market position. Recognised for its excellence, Agilus Diagnostics continues to drive advancements in healthcare diagnostics, making a meaningful impact on patient outcomes and the broader medical community.
DitchCarbon Score
How does Agilus Diagnostics Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Agilus Diagnostics Limited's score of 18 is lower than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Agilus Diagnostics Limited's reported carbon emissions
Agilus Diagnostics Limited, headquartered in India, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Fortis Healthcare Limited, which may influence its climate commitments and reporting practices. While Agilus Diagnostics has not set specific reduction targets or made notable climate pledges, it is important to note that its parent company, Fortis Healthcare Limited, may have its own sustainability initiatives and emissions data that could impact Agilus Diagnostics' environmental strategies. However, details regarding these initiatives or specific emissions figures from Fortis Healthcare Limited have not been provided. As a part of the healthcare sector, Agilus Diagnostics is positioned within an industry that increasingly prioritises sustainability and carbon footprint reduction. The absence of reported emissions data suggests an opportunity for the company to enhance its climate commitments and align with industry standards for transparency and accountability in environmental impact.
How Carbon Intensive is Agilus Diagnostics Limited's Industry?
How Carbon Intensive is Agilus Diagnostics Limited's Location?
Agilus Diagnostics Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Agilus Diagnostics Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
